Interstitial lung diseases (ILDs) are a group of diffuse parenchymal lung disorders that are classified according to different clinical, radiological and histopathological features. Interstitial lung disease can be primary or it can be due to a secondary cause, such as an underlying connective tissue disease (CTD). Rheumatoid arthritis (RA) is the most common CTD, and ILD can be found in a quarter of RA patients. Interstitial lung disease has a significant impact on RA patients in terms of their burden of disease and quality of life. Despite this it remains largely understudied and pathogenesis is unclear. Newer imaging techniques include ultrasound and 18F-FDG PET/CT. Therapeutics that show promise include mycophenolate mofetil and rituximab. Paradoxically, some of the agents that are good in treating articular manifestations in RA patients can result in the worsening or development of ILD.
SocietyASocietyE. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic and the European Respiratory was adopted by the ATS board of directors June and by the Committee JuneAm Crit Care Med2002;165(2):277–304 doi: 10.1164/ajrccm.165.2.ats01.
2.
HunninghakeGWFauciAS. Pulmonary involvement in the collagen vascular diseases. Am Rev Respir Dis1979;119(3):471–503.
HantFNHerpelLBSilverRM. Pulmonary manifestations of scleroderma and mixed connective tissue disease. Clin Chest Med2010;31(3):433–49 doi: 10.1016/j.ccm.2010.05.004.
5.
AubartFCrestaniBNicaise-RolandPTubachFBolletCDawidowiczK. High levels of anti-cyclic citrullinated peptide autoantibodies are associated with co-occurrence of pulmonary diseases with rheumatoid arthritis. J Rheumatol2011;38(6):979–82 doi: 10.3899/jrheum.101261.
6.
ConnorsGRChristopher-StineLOddisCVDanoffSK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: What progress has been made in the past 35 years?Chest2010;138(6):1464–74 doi: 10.1378/chest.10–0180.
7.
ItoINagaiSKitaichiMNicholsonAGJohkohTNomaS. Pulmonary manifestations of primary Sjogren's syndrome: A clinical, radiologic, and pathologic study. Am J Respir Crit Care Med2005;171(6):632–8 doi: 10.1164/rccm.200403-417OC.
8.
AlarconG. Unclassified or undifferentiated connective tissue disease. Best Pract Res Clin Rheumatol2000;14:125–37 doi: 10.1053/berh.1999.0081.
9.
CarmierDMarchand-AdamSDiotPDiotE. Respiratory involvement in systemic lupus erythematosus. Rev Mal Respir2010;27(8):e66–78 doi: 10.1016/j.rmr.2010.01.003.
McDonaghJGreavesMWrightARHeycockCOwenJ PKellyC. High resolution computed tomography of the lungs in patients with rheumatoid arthritis and interstitial lung disease. Br J Rheumatol1994;33(2):118–22 doi: 10.1093/rheumatology/33.2.118.
12.
StrangeCHighlandKB. Interstitial lung disease in the patient who has connective tissue disease. Clin Chest Med2004;25(3):549–59 doi: 10.1016/j.ccm.2004.05.009.
13.
MittooSGelberACChristopher-StineLHortonMRLechtzinNDanoffSK. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med2009;103(8):1152–8 doi: 10.1016/j.rmed.2009.02.009.
14.
EllmanPBallRE. “Rheumatoid disease” with joint and pulmonary manifestations. Br Med J1948;2(4583):816–20 doi: 10.1136/bmj.2.4583.816.
15.
BongartzTNanniniCMedina-VelasquezYFAchenbachSJCrowsonCSRyuJH. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: A population-based study. Arthritis Rheum2010;62(6):1583–91 doi: 10.1002/art.27405.
16.
WeyandCMSchmidtDWagnerUGoronzyJJ. The influence of sex on the phenotype of rheumatoid arthritis. Arthritis Rheum1998;41(5):817–22 doi: 10.1002/1529-0131(199805)41:5<817::AID-ART7>3.0.CO;2-S.
17.
Linn-RaskerSPvan der Helm-Van MilAHMvan GaalenFAKloppenburgMde VriesRRPle CessieS. Smoking is a risk factor for anti-CCP antibodies only in rheumatoid arthritis patients who carry HLA-DRB1 shared epitope alleles. Ann Rheum Dis2006;65(3):366–71 doi: 10.1136/ard.2005.041079.
18.
AlexiouIGermenisAKoutroumpasAKontogianniATheodoridouKSakkasLI. Anti-cyclic citrullinated peptide-2 (CCP2) autoantibodies and extra-articular manifestations in Greek patients with rheumatoid arthritis. Clin Rheumatol2008;27(4):511–3 doi: 10.1007/s10067-007-0800-1.
19.
InuiNEnomotoNSudaTKageyamaYWatanabeHChidaK. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis. Clin Biochem. 2008;41(13):1074–7.
20.
ZhuJZhouYChenXLiJ. A metaanalysis of the increased risk of rheumatoid arthritis-related pulmonary disease as a result of serum anticitrullinated protein antibody positivity. J Rheumatol2014;41(7):1282–9 doi: 10.3899/jrheum.131341.
21.
AschermanD P. Interstitial lung disease in rheumatoid arthritis. Curr Rheumatol Rep2010;12(5):363–9 doi: 10.1007/s11926-010-0116-z.
22.
ParkJHKimDSParkINJangSJKitaichiMNicholsonAG. Prognosis of fibrotic interstitial pneumonia: Idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med2007;175(7):705–11 doi: 10.1164/rccm.200607-912OC.
23.
YoungAKoduriGBatleyMKulinskayaEGoughANortonS. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. Rheumatology2007;46(2):350–7 doi: 10.1093/rheumatology/kel253.
24.
KlareskogLStoltPLundbergKKällbergHBengtssonCGrunewaldJ. A new model for an etiology of rheumatoid arthritis: Smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum2006;54(1):38–46 doi: 10.1002/art.21575.
25.
FischerASolomonJJdu BoisRMDeaneKDOlsonALFernandez-PerezER. Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease. Respir Med2012;106(7):1040–7 doi: 10.1016/j.rmed.2012.03.006.
26.
ReynisdottirGNyrenSHarjuASkoldMEklundAEngstromM. Lung changes detected by high resolution tomography are present in ACPA positive RA patients already at disease onset. Arthritis Rheum2011;63(Suppl 10):2176.
27.
MakrygiannakisDHermanssonMUlfgrenAKNicholasA PZendmanAJWEklundA. Smoking increases peptidylarginine deiminase 2 enzyme expression in human lungs and increases citrullination in BAL cells. Ann Rheum Dis2008;67(10):1488–92 doi: 10.1136/ard.2007.075192.
28.
HomerRJEliasJALeeCGHerzogE. Modern concepts on the role of inflammation in pulmonary fibrosis. Arch Pathol Lab Med2011;135(6):780–8 doi: 10.1043/2010-0296-RA.1.
29.
PengXMathaiSKMurrayLARussellTReilkoffRChenQ. Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor β1-induced lung fibrosis. Fibrogenesis Tissue Repair2011;4(1):12 doi: 10.1186/1755-1536-4-12.
30.
TokumuraACarboneLDYoshiokaYMorishigeJKikuchiMPostlethwaiteA. Elevated serum levels of arachidonoyl-lysophosphatidic acid and sphingosine 1-phosphate in systemic sclerosis. Int J Med Sci2009;6(4):168–76 doi: 10.7150/ijms.6.168.
31.
BrissettMVeraldiKLPilewskiJMMedsgerTAFeghali-BostwickCA. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3. Arthritis Rheum2012;64(1):272–80 doi: 10.1002/art.30647.
32.
MurrayLAChenQKramerMSHessonDPArgentieriRLPengX. TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. Int Cell Biol2011;3:154–62 doi: 10.1016/j.biocel.2010.10.013.
33.
MathaiSKGulatiMPengXRussellTRShawACRubinowitzAN. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest2010;90(6):812–23 doi: 10.1038/labinvest.2010.73.
34.
YoshizakiAIwataYKomuraKOgawaFHaraTMuroiE. CD19 regulates skin and lung fibrosis via Tolllike receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol2008;172(6):1650–63 doi: 10.2353/ajpath.2008.071049.
35.
RadstakeTRDJvan BonLBroenJWeninkMSantegoetsKDengY. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PloS ONE2009;4(6):e5981 doi: 10.1371/journal.pone.0005981.
36.
TruchetetMEBrembillaNCMontanariEAllanoreYChizzoliniC. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: Association with interstitial lung disease. Arthritis Res Ther2011;13(5):R166 doi: 10.1186/ar3486.
37.
YoshizakiAYanabaKOgawaAAsanoYKadonoTSatoS. Immunization with DNA topoisomerase I and Freund's complete adjuvant induces skin and lung fibrosis and autoimmunity via interleukin-6 signaling. Arthritis Rheum2011;63(11):3575–85 doi: 10.1002/art.30539.
38.
KellyCASaravananVNisarMArthanariSWoodheadFAPrice-ForbesAN. Rheumatoid arthritis-related interstitial lung disease: Associations, prognostic factors and physiological and radiological characteristics-a large multicentre UK study. Rheumatology2014;53(9):1676–82 doi: 10.1093/rheumatology/keu165.
LeeHKKimDSYooBSeoJBRhoJYColbyTV. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest2005;127(6):2019–27 doi: 10.1378/chest.127.6.2019.
RajasekaranBAShovlinDLordPKellyCA. Interstitial lung disease in patients with rheumatoid arthritis: A comparison with cryptogenic fibrosing alveolitis. Rheumatology2001;40(9):1022–5 doi: 10.1093/rheumatology/40.9.1022.
43.
DawsonJKFewinsHEDesmondJLynchMPGrahamDR. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis. Ann Rheum Dis2002;61(6):517–21 doi: 10.1136/ard.61.6.517.
44.
BradleyBBranleyHMEganJJGreavesMSHansellDMHarrisonNK. Interstitial lung disease guideline: The British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society. Thorax2008;63 (Suppl 5):v1–58 doi: 10.1136/thx.2008.101691.
45.
SathiNUrwinTDesmondSDawsonJK. Patients with limited rheumatoid arthritis-related interstitial lung disease have a better prognosis than those with extensive disease. Rheumatology2011;50(3):620 doi: 10.1093/rheumatology/keq426.
RaghuGMagetoYNLockhartDSchmidtRAWoodDEGodwinJD. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: A prospective study. Chest1999;116(5):1168–74 doi: 10.1378/chest.116.5.1168.
48.
HunninghakeGWZimmermanMBSchwartzDAKingTELynchJHegeleR. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med2001;164(2):193–6 doi: 10.1164/ajrccm.164.2.2101090.
49.
KimEJCollardHRKingTE. Rheumatoid arthritis-associated interstitial lung disease: The relevance of histopathologic and radiographic pattern. Chest2009;136(5):1397–405 doi: 10.1378/chest.09-0444.
50.
GarganiLDoveriMD'ErricoLFrassiFBazzichiMLDelle SedieA. Ultrasound lung comets in systemic sclerosis: A chest sonography hallmark of pulmonary interstitial fibrosis. Rheumatology2009;48(11):1382–7 doi: 10.1093/rheumatology/kep263.
51.
BarskovaTGarganiLGuiducciSRandoneSBBruniCCarnesecchiG. Lung ultrasound for the screening of interstitial lung disease in very early systemic sclerosis. Ann Rheum Dis2013; 72(3):390–5 doi: 10.1136/annrheumdis-2011-201072.
52.
CogliatiCAntivalleMTorzilloDBirocchiSNorsaABiancoR. Standard and pocket-size lung ultrasound devices can detect interstitial lung disease in rheumatoid arthritis patients. Rheumatology2014;53(8):1497–503 doi: 10.1093/rheumatology/keu033.
53.
MoritaYKuwagataSKatoNTsujimuraYMizutaniHSuehiroM. 18F-FDG PET/CT useful for the early detection of rapidly progressive fatal interstitial lung disease in dermatomyositis. Intern Med2012;51(12):1613–8 doi: 10.2169/internalmedicine.51.6813.
54.
SongJDoKKimMJangSColbyTKimD. Pathologic and radiologic differences between idiopathic and collagen vascular disease-related usual interstitial pneumonia. Chest2009;136(1):23–30 doi: 10.1378/chest.08-2572.
55.
VassalloRThomasCF. Advances in the treatment of rheumatic interstitial lung disease. Curr Opin Rheumatol2004;16(3):186–91.
56.
TashkinD PElashoffRClementsPJGoldinJRothMDFurstDE. Cyclophosphamide versus placebo in scleroderma lung disease. N Engl J Med2006;354(25):2655–66 doi: 10.1056/NEJMoa055120.
57.
TashkinD PElashoffRClementsPJRothMDFurstDESilverRM. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med2007;176(10):1026–34 doi: 10.1164/rccm.200702-326OC.
58.
SaketkooLAEspinozaLR. Rheumatoid arthritis interstitial lung disease: Mycophenolate mofetil as an antifibrotic and disease-modifying antirheumatic drug. Arch Intern Med2008;168(15):1718–9 doi: 10.1001/archinte.168.15.1718.
59.
TzouvelekisAGalanopoulosNBourosEKoliosGZacharisGNtoliosP. Effect and safety of mycophenolate mofetil or sodium in systemic sclerosis-associated interstitial lung disease: A meta-analysis. Pulm Med2012;2012:143637 doi: 10.1155/2012/143637.
60.
GerbinoAJGossCHMolitorJA. Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease. Chest2008;133(2):455–60 doi: 10.1378/chest.06-2861.
61.
Simeon-AznarCFonollosa-PlaVTolosa-VilellaCSelva-O'CallaghanASolans-LagueRVilardell-TarresM. Effect of mycophenolate sodium in scleroderma-related interstitial lung disease. Clin Rheumatol2011;30(11):1393–8 doi: 10.1007/s10067-011-1823-1.
62.
AtkinsSRTuressonCMyersJLTazelaarHDRyuJHMattesonEL. Morphologic and quantitative assessment of CD20+ B cell infiltrates in rheumatoid arthritis-associated nonspecific interstitial pneumonia and usual interstitial pneumonia. Arthritis Rheum2006;54(2):635–41 doi: 10.1002/art.21758.
63.
MattesonELDellaripaPFRyuJHCrowsonCSHartmanTEBongartzT. Open-label, pilot study of the safety and clinical effects of Rituximab in patients with rheumatoid arthritis-associated interstitial pneumonia. Arthritis Rheum2011;63(Suppl 10):2212.
64.
DaoussisDLiossisSNCTsamandasACKalogeropoulouCKazantziASirinianC. Experience with rituximab in scleroderma: Results from a 1-year, proof-of-principle study. Rheumatology2010;49(2):271–80 doi: 10.1093/rheumatology/kep093.
65.
SemMMolbergOLundMBGranJT. Rituximab treatment of the anti-synthetase syndrome: A retrospective case series. Rheumatology2009;48(8):968–71 doi: 10.1093/rheumatology/kep157.
66.
LimSWGillisDSmithWHissariaPGrevilleHPehCA. Rituximab use in systemic lupus erythematosus pneumonitis and a review of current reports. Intern Med J2006;36(4):260–2 doi: 10.1111/j.1445-5994-2006.01055.x.
67.
NgKPLeandroMJEdwardsJCEhrensteinMRCambridgeGIsenbergDA. Repeated B cell depletion in treatment of refractory systemic lupus erythematosus. Ann Rheum Dis2006;65(7):942–5 doi: 10.1136/ard.2005.044487.
68.
SmolenJSLandewéRBreedveldFCBuchMBurmesterGDougadosM. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis2014;73(3):492–509 doi: 10.1136/annrheumdis-2013-204573.
69.
ChikuraBSathiNLaneSDawsonJK. Variation of immunological response in methotrexate-induced pneumonitis. Rheumatology2008;47(11):1647–50 doi: 10.1093/rheumatology/ken356.
70.
HowesMToseJWhiteCKumarNHeycockCKellyC. Can baseline pulmonary function tests predict pulmonary toxicity in patients receiving methotrexate for rheumatoid arthritis?Intern Med1999;7:51–4.
71.
KamataYNaraHKamimuraTHanedaKIwamotoMMasuyamaJ. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med2004;43(12):1201–4 doi: 10.2169/internalmedicine.43.1201.
72.
ChikuraBLaneSDawsonJK. Clinical expression of leflunomide-induced pneumonitis. Rheumatology2009;48(9):1065–8 doi: 10.1093/rheumatology/kep050.
73.
Perez-AlvarezRPerez-De-LisMDiaz-LagaresCPego-ReigosaJMRetamozoSBoveA. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: Analysis of 122 cases. Semin Arthritis Rheum2011;41(2):256–64 doi: 10.1016/j.semarthrit.2010.11.002.
74.
KishiJNankiTWatanabeKTakamuraAMiyasakaN. A case of rituximab-induced interstitial pneumonitis observed in systemic lupus erythematosus. Rheumatology2009;48(4):447–8 doi: 10.1093/rheumatology/kep015.
75.
SoubrierMJeanninGKemenyJLTournadreACaillotNCaillaudD. Organizing pneumonia after rituximab therapy: Two cases. Joint Bone Spine2008;75(3):362–5 doi: 10.1016/j.jbspin.2007.10.009.
76.
OkadaYTeraoCIkariKKochiYOhmuraKSuzukiA. Meta-analysis identifies nine new loci associated with rheumatoid arthritis in the Japanese population. Nat Genet2012;44(5):511–6 doi: 10.1038/ng.2231.
77.
OkadaYWuDTrynkaGRajTTeraoCIkariK. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature2014;506(7488):376–81 doi: 10.1038/nature12873.
78.
SuharaKMiyazakiYOkamotoTTateishiTFurusawaHTsuchiyaT. Proteomics analysis of BALF in rheumatoid arthritis associated interstitial lung disease with usual interstitial pneumonia pattern. Am J Resp Crit Care Med2013;187 (abstract issue):A3387.
79.
YtterbergAJoshuaVReynisdottirGTarasovaNRutishauserDOssipovaE. Shared immunological targets in the lungs and joints of patients with rheumatoid arthritis: Identification and validation. Ann Rheum Dis2014; doi: 10.1136/annrheumdis-2013-204912.
